UCLA leads CDC-funded study on effectiveness of vaccines, boosters in ‘next phase’ of COVID

The David Geffen School of Medicine at UCLA has been awarded a $13.6 million grant from the Centers for Disease Control and Prevention to continue to study the effectiveness of COVID-19 vaccines and the long-term impact of infection among U.S. health care workers. The new yearlong grant project follows the 2020–21 Preventing Emerging Infections Through Vaccine Effectiveness Testing study, or PREVENT I, which was among the first to demonstrate the real-world benefit of mRNA vaccines in preventing symptomatic infection following their authorization by the Food and Drug Administration.

The CDC recommended that pregnant people be vaccinated against COVID-19. Learn more from BIDMC’s Dr. Ai-ris Collier, who has led research evaluating the immunogenicity of COVID-19 mRNA vaccines.

Ai-ris Collier, MD, a Maternal-Fetal Medicine specialist at Beth Israel Deaconess Medical Center, is available for expert comment regarding the Centers for Disease Control and Prevention’s recommendation that pregnant people be vaccinated against COVID-19. Dr. Collier has led research published…

Study shows rapid return of respiratory viruses after COVID-19 restrictions relaxed

A new Houston Methodist study shows a rapid return of seasonal respiratory viruses after COVID-19 restrictions were relaxed in Texas, demonstrating the apparent effectiveness of masking, distancing and other precautionary measures at stopping the spread of respiratory illnesses. This rise in infections to pre-pandemic levels followed updated governmental guidelines lifting mask, distancing and occupancy requirements.